7Shin JM, Besancon M, Simon A, et al. The site of action of panto- prazole in the gastric H , K + -ATPase [ J ]. Biochim Biophvs Acta, 1993,1148:223-233.
8Tian C, Zhu L, Yu D, et al. The Stereoselectivity of CYP2C19 on R- and S- isomer of Proton Pump In- hibitors[J]. Chem Biol Drug Des, 2014,83 (5) .. 610 - 621.
9Ogilvie BW, Yerino P, Kazmi F, et al. The proton pump inhibitor, omepraole, but not lansoprazole or pantoprazole, is a metabolism- dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel[J]. Drug Metab Dispos, 2011,39 ( 11 ) .. 2020 - 2033.
10Ward RM,Kearns GL. Proton pump inhibitors in ped- iatrics., mechanism of action, pharmacokinetics, phar- macogenetics, and pharmacodynamics [ J ]: Paediatr Drugs, 2013,15(2) .. 119 - 131.